Skip to main content

Table 1 Laboratory findings from the admission

From: Anti-neutrophil cytoplasmic antibody-associated vasculitis accompanied by type II heparin-induced thrombocytopenia resulting in asymptomatic cerebral infarction: a case report

Urinalysis

Biochemistry, immunological, virologic, and coagulation parameters

Protein

3+

TP

6.9 g/dL

Ferritin

499 ng/mL

Occult blood

3+

Alb

3.3 g/dL

IgG

1,674 mg/dL

Red blood cells

> 100/HPF

UA

8.3 mg/dL

IgA

296 mg/dL

Protein

5.72 g/gCr

BUN

134.2 mg/dL

IgM

69 mg/dL

NGAL

1485 ng/mL

Cr

13.96 mg/dL

C3

79 mg/dL

NAG

17.8 U/L

eGFR

3 mL/min/1.73 m2

C4

27.3 mg/dL

α1MG

91.8 mg/L

TB

0.1 mg/dL

CH50

43 U/mL

β2MG

37,676 µg/L

AST

6 IU/L

Antinuclear Ab

1:40

Bence Jones protein

–

ALT

10 IU/L

Anti-dsDNA Ab

–

Complete blood cell count

ALP

249 IU/L

Anti-smith Ab

–

White blood cells

6,300/µL

γ-GT

16 IU/L

Anti-CL-β2GP1 Ab

–

Neutrophils

75.10 %

LDH

166 IU/L

Direct Coombs test

–

Lymphocytes

13.30 %

CK

64 IU/L

Anti-MPO-ANCA

1,700 IU/mL

Monocytes

5.90 %

Na

134 mEq/L

Anti-PR3-ANCA

–

Eosinophils

5.20 %

K

6.3 mEq/L

Cryoglobulin

–

Red blood cells

238 × 104/µL

Cl

102 mEq/L

HIV Ag/Ab

–

Hemoglobin

7.5 g/dL

cCa

7.7 mg/dL

HBs Ag/HBc Ab

–

Hematocrit

22.60 %

IP

7.3 mg/dL

HCV Ab

–

Platelets

15.8 × 104/µL

CRP

2.47 mg/dL

PT

94 %

  

TC

147 mg/dL

APTT

24.9 s

  

TG

220 mg/dL

D-dimer

4.1 µg/mL

  

HbA1c

5.40 %

  
  

HANP

340.6 pg/mL

  
  

BNP

140.0 pg/mL

  
  1. NAG N-acetyl-beta-D-glucosaminidase, NAGL NAG ligand, α1MG alpha1-microglobulin, β2MG beta2-microglobulin, TP total protein, Alb albumin, UA uric acid, BUN blood urea nitrogen, Cr creatinine, eGFR estimated glomerular filtration rate, AST aspartate transaminase, ALT alanine transaminase, ALP alkaline phosphatase, γ-GT gamma-glutamyl transferase, LDH lactate dehydrogenase, CK creatine kinase, CRP C-reactive protein, TC total cholesterol, TG triglycerides, HBa1c glycated hemoglobin, BNP brain natriuretic peptide, ANCA anti-neutrophil cytoplasmic autoantibody, HIV human immunodeficiency virus, PT prothrombin time, APTT activated partial thromboplastin time